Yibing Wu

Yibing Wu is a Chinese investment banker.

According to his Gavi biography, Wu received his Ph.D. in Biochemistry and Molecular Biology from Harvard University in 1996.¹⁾ However, his LinkedIn profile claims he received a Bachelor's Degree in Molecular Biology from the University of Science and Technology of China after studying from 1985-1989, and then a Doctor of Philosophy from Harvard from 1989-1996.²⁾

After graduating from Harvard, Wu immediately started work at McKinsey & Company, joining their Beijing office in 1996 and becoming Managing Partner of the Asia-Pacific practice in 2004.

During this time, he worked on several Chinese IPOs including the China Construction Bank and the People’s Insurance Company of China (PICC).

Wu acted as Chief Strategy Officer at Lenovo from 2005-2008.

Wu has acted as a board member for the YouChange, China Social Entrepreneur Foundation since 2007.³⁾

Wu led the acquisition and integration of the IBM PC business into Legend Holdings, rising to Executive Vice-President and Managing Director of the organization in 2008.

In 2009, Wu co-founded CITIC Private Equity Funds Management, a China-focused domestic private equity firm with more than US$ 13 billion in total assets under management. Whilst remaining at CITIC, in 2012, Wu joined Goldstone Investment Company (the direct investment arm of CITIC Securities) as Chairman and CEO for 18 months.⁴⁾

Wu joined Temasek in October 2013 as Head of China.⁵⁾ He is also the President of the Enterprise Development Group, and Joint Head of the Portfolio Strategy and Risk Group.⁶⁾

Wu is a member of the board of directors for Gavi, the Vaccine Alliance.⁷⁾

Wu's LinkedIn interests include Larry Fink, CEO of BlackRock, and Temasek Life Sciences Laboratory.⁸⁾